Induction of a Macrophage-suppressive Lymphokine by Soluble Cryptococcal Antigens and Its Association with Models of Immunologic Tolerance
Overview
Authors
Affiliations
Soluble extracts of Cryptococcus neoformans were examined for their ability to induce a macrophage-regulatory T-suppressor cell known to appear in the spleens of mice infected with cryptococci. Suppressor cells were induced by injection of extracts of encapsulated or thinly encapsulated strains of cryptococci. Dose-response analysis showed that as little as 25 micrograms of soluble capsular polysaccharide antigen could induce significant suppressor cell activity, with maximum suppression occurring at a dose of 100 micrograms. The suppressor cells appeared within 1 week of injection of antigen and persisted for at least 2 months. Suppressor cells were induced in animals given tolerogenic doses of levan, human gamma globulin, and soluble capsular polysaccharide antigen. When these same antigens were administered in immunogenic form, no suppressor cell activity was detected. Therefore, the suppressive mechanism was common to models of immunologic tolerance and was not unique to cryptococcal disease or cryptococcal capsular polysaccharide antigen. The phagocytosis-inhibiting lymphokine produced by the suppressor cell population completely inhibited the phagocytic activity of only a portion of peritoneal exudate cells. Other macrophages in the population were not totally inhibited but exhibited a reduction in the number of yeast cells engulfed.
The capsule of the fungal pathogen Cryptococcus neoformans.
Zaragoza O, Rodrigues M, De Jesus M, Frases S, Dadachova E, Casadevall A Adv Appl Microbiol. 2009; 68:133-216.
PMID: 19426855 PMC: 2739887. DOI: 10.1016/S0065-2164(09)01204-0.
Chiapello L, Baronetti J, Aoki M, Gea S, Rubinstein H, Masih D Immunology. 2004; 113(3):392-400.
PMID: 15500627 PMC: 1782585. DOI: 10.1111/j.1365-2567.2004.01970.x.
Blackstock R Immunology. 2003; 108(2):158-66.
PMID: 12562324 PMC: 1782881. DOI: 10.1046/j.1365-2567.2003.01574.x.
Blackstock R, McElwee N, Neller E Infect Immun. 2000; 68(9):5146-53.
PMID: 10948138 PMC: 101763. DOI: 10.1128/IAI.68.9.5146-5153.2000.
Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan.
Wang Y, Li S, Moser S, Bost K, Domer J Infect Immun. 1998; 66(4):1384-91.
PMID: 9529057 PMC: 108064. DOI: 10.1128/IAI.66.4.1384-1391.1998.